UN member states have agreed to hold a Ministerial Segment immediately prior to the 62nd Session of the Commission on Narcotic Drugs (CND) ‘to take stock of the implementation of the commitments made to jointly address and counter the world drug problem, in particular in the light of the 2019 target date’1 set out to eradicate or significantly reduce the overall scale of the illegal drug market. This advocacy note outlines the key issues for consideration by member states as they reflect on what has been achieved since the adoption of the 2009 Political Declaration and Plan of Action, including in light of the implementation of the UNGASS Outcome Document, and the implications for the next phase of the international drug policy regime. In addition, we provide recommendations to address some of the outstanding procedural questions related to the Ministerial Segment in Vienna.
- FAST-TRACK or OFF TRACK? How insufficient funding for key populations jeopardises ending AIDS by 2030
- Women and barriers to harm reduction services: A literature review and initial findings from a qualitative study in Barcelona, Spain
- Clean Start: Creating second chances for women and girls in Kenya
- Addressing the syndemic of HIV, hepatitis C, overdose, and COVID-19 among people who use drugs: the potential roles for decriminalization and safe supply
- How diverse is Canada’s legal cannabis industry? Examining race and gender of its executives and directors
- Coca and Its medical applications: Prospects, obstacles and lessons learned
- Funding what is possible. Robert Carr fund annual report 2019.
- The impact of arrest and seizure on drug crime and harms: A systematic review
- Addressing stigma and discrimination in the COVID-19 response